Suhayl Dhib-Jalbut

Overview

Best Publications

• Brain health: time matters in multiple sclerosis

  Gavin Giovannoni;Helmut Butzkueven;Suhayl Dhib-Jalbut;Jeremy Hobart

  495
  Citations

• Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 1.

  M K Racke;S Dhib-Jalbut;B Cannella;P S Albert

  450
  Citations

• Interferon-β mechanisms of action in multiple sclerosis

  Suhayl Dhib-Jalbut;Steven Marks

  387
  Citations

• Sustained clinical benefits of glatiramer acetate in relapsing multiple sclerosis patients observed for 6 years

  K. P. Johnson;B. R. Brooks;C. C. Ford;A. Goodman

  339
  Citations

• Mechanisms of action of interferons and glatiramer acetate in multiple sclerosis

  Suhayl Dhib-Jalbut

  256
  Citations

• Mechanisms of immunomodulation by glatiramer acetate.

  B. Gran;L. R. Tranquill;M. Chen;B. Bielekova

  227
  Citations

• Advances in the immunopathogenesis of multiple sclerosis.

  Sudhir K. Yadav;John E. Mindur;Kouichi Ito;Suhayl Dhib-Jalbut

  219
  Citations

• Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: a randomised, placebo-controlled, phase 2 trial.

  Rhonda R. Voskuhl;He Jing Wang;T. C.Jackson Wu;Nancy L. Sicotte

  217
  Citations

• Hematopoietic progenitors express neural genes

  James Goolsby;Marie C. Marty;Dafna Heletz;Joshua Chiappelli

  213
  Citations

• The effects of 4‐aminopyridine in multiple sclerosis patients Results of a randomized, placebo‐controlled, double‐blind, concentration‐controlled, crossover trial

  Christopher T. Bever;Christopher T. Bever;D. Young;P. A. Anderson;A. Krumholz

  201
  Citations

• Isolation of HTLV-II from a patient with chronic, progressive neurological disease clinically indistinguishable from HTLV-I-associated myelopathy/tropical spastic paraparesis

  Steven Jacobson;Tanya Lehky;Masataka Nishimura;Susan Robinson

  168
  Citations

• Phase 1 trial of transforming growth factor beta 2 in chronic progressive MS

  Peter A. Calabresi;N. S. Fields;H. W. Maloni;A. Hanham

  160
  Citations

• Interferon β-lb reduces Interferon γ-induced antigen-presenting capacity of human glial and B cells

  Hong Jiang;Ron Milo;Peggy Swoveland;Kenneth P. Johnson

  149
  Citations

• Glatiramer acetate-reactive T cells produce brain-derived neurotrophic factor

  Man Chen;Reuben Mari Valenzuela;Reuben Mari Valenzuela;Suhayl Dhib-Jalbut;Suhayl Dhib-Jalbut

  148
  Citations

• IFN-β-1b Inhibits IL-12 Production in Peripheral Blood Mononuclear Cells in an IL-10-Dependent Mechanism: Relevance to IFN-β-1b Therapeutic Effects in Multiple Sclerosis

  Xin Wang;Xin Wang;Man Chen;Man Chen;Klaus Peter Wandinger;Gary Williams

  146
  Citations

• Pathogenesis of myelin/oligodendrocyte damage in multiple sclerosis.

  Suhayl Dhib-Jalbut

  144
  Citations

• Human T-cell leukemia virus type I infection of monocytes and microglial cells in primary human cultures

  Paul M. Hoffman;Suhayl Dhib-Jalbut;Suhayl Dhib-Jalbut;Judy A. Mikovits;Deanna S. Robbins;Deanna S. Robbins

  137
  Citations

• Brain-derived neurotrophic factor gene delivery in an animal model of multiple sclerosis using bone marrow stem cells as a vehicle.

  Tapas K. Makar;Christopher T. Bever;Ishwar S. Singh;Walter Royal

  137
  Citations

• Glatiramer acetate induces a Th2-biased response and crossreactivity with myelin basic protein in patients with MS.

  M Chen;B Gran;K Costello;K Johnson

  136
  Citations

• Neurodegeneration and neuroprotection in multiple sclerosis and other neurodegenerative diseases.

  Suhayl Dhib-Jalbut;Douglas L. Arnold;Don W. Cleveland;Mark Fisher

  126
  Citations